Skip to main content
. 2007 Nov 6;97(11):1588–1594. doi: 10.1038/sj.bjc.6604080

Table 5. Ranking of selected diagnostic groups based on the number (N) of deaths from 1981 to 2005 and ranking based on the number of new cases registered in England from 1979 to 2003 in persons at 13–29 years.

  Mortality
Incidence
 
Group N % a Rank N % b Rank I:M ratio c
Eye, brain, and other parts of CNS 2473 13.9 1 6003 8.2 4 2.4
Myeloid and monocytic leukaemia 1899 10.7 2 3095 4.2 8 1.6
Lymphoid leukaemia 1843 10.4 3 2663 3.7 11 1.4
Bone and articular cartilage 1538 8.7 4 2760 3.8 10 1.8
Non-Hodgkin's lymphoma 1513 8.5 5 4873 6.7 6 3.2
Hodgkin's lymphoma 1209 6.8 6 9778 13.4 1 8.1
Mesothelial and soft tissue 1019 5.7 7 2539 3.5 13 2.5
Melanoma of skin 731 4.1 8 6744 9.3 3 9.2
Cervix 713 4.0 9 5520 7.6 5 7.7
Breast 683 3.9 10 3874 5.3 7 5.7
Testis 590 3.3 11 9757 13.4 2 16.5
Other sites in GI tract 487 2.7 12 819 1.1 19 1.7
Colorectal 485 2.7 13 1511 2.1 16 3.1
Respiratory and intrathoracic organs 402 2.3 14 1051 1.4 18 2.6
Ovary 376 2.1 15 2417 3.3 14 6.4
Benign and uncertain behaviour - CNS 373 2.1 16 2627 3.6 12 7.0
Other sites in GU organs 338 1.9 17 1762 2.4 15 5.2
Liver 295 1.7 18 389 0.5 20 1.3
Lip, oral cavity, and pharynx 276 1.6 19 1254 1.7 17 4.5
Thyroid and other endocrine glands 272 1.5 20 3063 4.2 9 11.3
Other and unspecified lympho-haematopoietic 222 1.3 21 381 0.5 21 1.7
All groups 17 737 100   72 880 100   4.1
a

Percentage of all deaths.

b

Percentage of all new cases.

c

Incidence to mortality ratio; number of new cases divided by number of deaths.